Text size :

Pharmaceuticals, Cappellacci (Fi): “New Consolidated Law brings care closer to citizens”

ADNKRONOS

November 9, 2026

Rome, Nov 9. (Adnkronos Health) – “The new Consolidated Law on pharmaceutical legislation should bring about the important and substantial change of bringing care closer to citizens. This is the first aspect that, evidently, concerns everyone.” This was stated by Ugo Cappellacci (FI), president of the XII Social Affairs Committee of the Chamber, speaking at the event “The future of pharmaceutical legislation: a systemic vision,” organized by Nuove Reti in Rome.

“Then there is the aspect concerning the pharmaceutical industry – he underlined – which should allow it to work towards its objectives, also encouraging greater investments, without falling into the jungle of bureaucratic requirements, through regional simplification. Furthermore, the new Consolidated Law brings order to legislation that is currently very fragmented, which has stratified over time and needs revision.”

According to Cappellacci, among the many aspects on which the Consolidated Law impacts, “some are more important than others. I believe the most important aspect is to facilitate care for citizens, accelerating timelines, making a drug accessible more quickly and, at the same time, encouraging the industry to invest in that drug. Today, especially in the international context, difficulties arise when territories are unable to value the contribution in terms of investments, not only for production but also for research,” he concluded.

Jiji Press

Related

Page TOP